Novel technology developed can help identify early-stage lung cancer, reports a new study. The findings of the study are published in iThe Journal of Molecular Diagnostics/i.
Non-small-cell lung carcinoma (NSCLC) is often fatal because most cases are not diagnosed until they are so advanced that surgical intervention is no longer possible. To improve outcomes researchers are developing a blood test to detect lung cancer earlier in the disease.
A report describes a new technology, electric ...
Novel technology developed can help identify early-stage lung cancer, reports a new study. The findings of the study are published in iThe Journal of Molecular Diagnostics/i.
Non-small-cell lung carcinoma (NSCLC) is often fatal because most cases are not diagnosed until they are so advanced that surgical intervention is no longer possible. To improve outcomes researchers are developing a blood test to detect lung cancer earlier in the disease.
A report describes a new technology, electric ...